Globally, the incidence of sarcoma in young adults is approximately 2/100,000 persons with a greater incidence in males over females by a 2:1 ratio. Previous radiation and chemotherapy exposure before the age of 20, as well as exposure to certain chemical agents, has been linked to an increased risk in the development of sarcoma in the young adult population. Young adult sarcoma patients seem to do worse then their pediatric counterparts for a variety of reasons, one being the differences in the biology of their cancers. These differences in biology need to be accounted for when establishing treatment plans in this age group in determining pediatric- versus adult-based protocols.
Source: Soliman H, Ferrari A, Thomas D. Sarcoma in the Young Adult Population: An International View. Semin Oncol. 2009; 36:227-236.
Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals.
Pediatr Blood Cancer. 2012 Jun 15;
Authors: Audino AN, Yeager ND, Asti L, Miao Y, O'Brien SH
BACKGROUND: Adolescent and...
Impact of cancer on work and education among adolescent and young adult cancer survivors.
J Clin Oncol. 2012 Jul 1;30(19):2393-400
Authors: Parsons HM, Harlan LC, Lynch CF, Hamilton AS, Wu XC, Kato I, Schwartz SM, Smith AW, Keel G, Keegan TH
Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study.
J Cancer Surviv. 2012 Mar 29;
Authors: Keegan TH, Lichtensztajn DY, Kato I, Kent EE, Wu XC, West MM, Hamilton AS, Zebrack B, Bellizzi KM, Smith AW, and the AYA HOPE Study...
Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007.
BMC Cancer. 2012;12:151
Authors: Haggar FA, Preen DB, Pereira G, Holman CDj, Einarsdottir K
BACKGROUND: Increasing incidence and...
Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult.
Cancer. 2012 Mar 13;
Authors: Bellizzi KM, Smith A, Schmidt S, Keegan TH, Zebrack B, Lynch CF, Deapen D, Shnorhavorian M, Tompkins BJ, Simon M, and the Adolescent and Young Adult Health Outcomes and...
Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
J Clin Oncol. 2011 Oct 20;29(30):4045-53
Authors: Parsons HM, Harlan LC, Seibel NL, Stevens JL, Keegan TH
Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead.
Crit Rev Oncol Hematol. 2012 Jun;82(3):259-79
Authors: Van Gaal JC, De Bont ES, Kaal SE, Versleijen-Jonkers Y, van der Graaf WT
Current issues in adolescent and young adult cancer survivorship.
Cancer Control. 2008 Jan;15(1):55-62
Authors: Soliman H, Agresta SV
BACKGROUND: Overall, the survival rate for cancer patients has continued to improve over the past several decades. However,...
Adolescent and young adult (AYA) oncology: the first A.
Pediatr Hematol Oncol. 2007 Jul-Aug;24(5):325-36
Authors: Bleyer A
Whereas adolescents with cancer as a group used to have a better prognosis than children with malignant disease, trends...
Overview of sarcomas in the adolescent and young adult population.
J Pediatr Hematol Oncol. 2005 Apr;27(4):215-8
Authors: Herzog CE
Based on the data of the...
[Chromosome and DNA analyses of peripheral blood lymphocyte from the quadruple cancer patient].
Gan To Kagaku Ryoho. 1992 Jul;19(7):1055-7
Authors: Yamaguchi H, Kaneda K, Aya T, Imai S, Yamawaki S, Moriuchi T
The patient with quadruple cancer was a 32 year-old female who had osteosarcoma, bilateral breast cancer and...
Sodium butyrate (SB) augments the effects of 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) on neoplastic and osteoblastic phenotype in clonal rat osteosarcoma cells.
Biochem Biophys Res Commun. 1984 Jun 29;121(3):796-801
Authors: Yoneda T, Aya S, Sakuda M
1,25 Dihydroxyvitamin D3 suppressed colony formation in soft agar and...
from patients, caregivers and medical professionals dealing with this disease and many other diseases